• ISSN: 2349-6002
  • UGC Approved Journal No 47859
Author Login IJIRT Partner Network (IPN) Login

A Study of Extracts of Rheum emodi in Experimental Non-Alcoholic Fatty Liver Disease

  • Unique Paper ID: 167204
  • Volume: 11
  • Issue: 3
  • PageNo: 576-583
  • Abstract:
  • Paracetamol (PCM) is a commonly used analgesic and antipyretic medication, however at large doses, it can cause hepatotoxicity/NAFLD. This study explores the therapeutic potential of Rheum e.modi extracts in treating experimental non-alcoholic fatty liver disease (NAFLD), a liver disorder linked to metabolic syndrome, based on its diverse phytochemical composition against paracetamol-induced damage. This study aims to evaluate the hepatoprotective effects of Rheum e.modi extracts on NAFLD in an experimental model, conduct histopathological examination of liver tissues, investigate the potential of Rheum e.modi extracts in modulating metabolic pathways related to lipid metabolism, insulin sensitivity, and glucose homeostasis, and establish a dose-response relationship to determine the optimal dosage for significant therapeutic effects while ensuring safety.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 3
  • PageNo: 576-583

A Study of Extracts of Rheum emodi in Experimental Non-Alcoholic Fatty Liver Disease

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry